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Viral myocarditisIL-17-producing (Th17) and regulatory T (Treg) cells have been well established in the pathogenesis of many
inﬂammatory diseases. To assess whether Th17 and Treg were altered in acute virus-induced myocarditis
(AVMC) mice, we assessed Th17/Treg functions on different levels in AVMC. It was shown that the expression
of splenic Th17 cells and Th17-related cytokines (IL-17A, IL-21)markedly increased. Interestingly, the expression
of splenic Treg cells and Treg-related cytokines (TGF-β, IL-10) also signiﬁcantly increased. Using neutralization of
IL-17 in the AVMC, we found that Treg cells roughly decreased compared with isotype control mice. However,
T cells and perforin dramatically increased, followed by amarked reduction in CVB3 replication. The results sug-
gested that Th17 cells possibly contributed to viral replication through the action of Treg cells inmediating T cells
and perforin response in AVMC.glin Road 180, Shanghai, China.
).
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Viralmyocarditis is a frequent cause of sudden death in young adults
and can progress to chronic dilated cardiomyopathy, a major cause of
heart failure associated with an autoimmune response (Feldman and
McNamara, 2000). Coxsackievirus B3 (CVB3)-induced acute myocardi-
tis occurs from day 7 to 14 post-infection in susceptible BALB/c mice
(Fairweather et al., 2001). CVB3-induced myocarditis is related to a
direct cytopathic effect of the virus or immune-mediated mechanisms.
Meanwhile, the negative modulation of host immune responses and
the autoimmune inﬂammatory activation is regulated by primary
T lymphocyte cells (Afanasyeva et al., 2001). Strikingly, cytotoxic T cells
are able to induce apoptosis of the virus-infected cells through perforin,
which acts by punching holes in cells that have been invaded by viruses.
The holes allow toxic enzymes entering into the cells, which in turn
destroy the cells. Interleukin-17 (IL-17) and Th17 cells have been
shown to play important roles in inﬂammation and immune response.
Recently, a general consensus has developed that Th17 cells play an
important role in autoimmune diseases, such as systemic lupus
erythematosus (SLE) and experimental autoimmune myocarditis
(EAM) (Doreau et al., 2009; Korn et al., 2009). Previous studies
have observed that systematic depletion of IL-17 inMyHC-α/CFA im-
munized mice both ameliorated the recruitment of inﬂammatory
cells and relieved disease severity by an anti-IL-17 antibody or by active
vaccination, indicating a direct pathogenic role of IL-17 in EAM(Sonderegger et al., 2006). Moreover, regulatory T (Treg) cells are a
thymus-derived distinct lineage of T cells that recognize and suppress
the expansion and function of potential self-reactive T cell clones, thus
maintaining peripheral self-tolerance (Vahlenkamp et al., 2005). It is
well accepted that Treg cells play a pivotal role in maintaining immune
homeostasis and preventing autoimmune disease. Th17 and Treg cells
are subsets of the CD4+ T cell compartment which are vital modulators
of the innate and adaptive immune response in many immune diseases
(Chauhan et al., 2009; Fantini et al., 2007; Ratajczak et al., 2010).
Previous investigations have shown that the generation of induced
Treg and Th17 cells is reciprocally regulated in autoimmune disease
(Bettelli et al., 2006). TGF-β has the ability to induce both RORγt
and Foxp3 expression in T cells in vitro, which depending on the
concentration (Zhou et al., 2008). Moreover, accumulating evidence
indicates that Th17 cells retain potential developmental plasticity
(Zhou et al., 2009), especially, Ye et al. (2011) provided the ﬁrst
evidence that human Th17 cells can differentiate into Treg cells
at the clonal level. However, the expression and function of Th17
and Treg cells in CVB3-infectedmyocarditis are still unclear. It is natural
to investigate the relationship between the levels of CVB3 replication
and Th17 and Treg cells. It is also important to evaluate the effects of
neutralization of IL-17A on differentiate into Treg cells, which may be
associated with Treg-mediated T cells and perforin response. To better
understand the effect of neutralization of IL-17 on Foxp3+ Treg cells
during acute viral infections, we examined the effects of activation of
immunosuppressive Foxp3+ Treg cells. Finally, activation of these
cells was capable of inhibiting anti-viral CD4+, CD8+ T cells and
perforin immune responses on day 7 in acute CVB3-inducedmyocardi-
tis. It was shown in the present study that viral load was possibly asso-
ciated with the changes of function and expression of Treg cells in
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viral replication in CVB3-induced acute myocarditis.
Results
Proportion of Th17 and Treg cells in viral myocarditis
Compared with those in the control group, the percentages of
CD4+ Th17 cells in AVMC markedly increased on days 7, 10, and 14.
Speciﬁcally, the percentages of CD4+ IL-17+ T cells on day 10 in myo-
carditis were remarkably higher than those on days 7 and 14 (all
pb0.01) (Figs. 1A and C). The percentages of CD4+CD25+ Treg cells
in the AVMC group were higher than those in the control group
(pb0.01) (Figs. 1B and D), however, no obvious difference could be
observed among days 7, 10 and 14 in the AVMC group.
Detection of cardiac IL-17A, TGF-βmRNA and CVB3 RNA on day 7 in viral
myocarditis
On day 7, the mRNA expression of cardiac IL-17 in AVMC was
markedly elevated compared to the normal control group (pb0.01,
Fig. 2A). Moreover, the mRNA expression of cardiac IL-17 positively
correlated with that of cardiac CVB3 (correlation index [R]=0.897;
pb0.01; Fig. 2C). Similarly, the levels of cardiac TGF-β in the AVMC
apparently increased compared to the normal control group (pb0.01,
Fig. 2B). The mRNA expression of cardiac TGF-β negatively correlated
with the RNA expression of cardiac CVB3 (R=−0.913; pb0.01;
Fig. 2D).
Relationships among pathological score, the proportion of CD4+,
CD8+, CD4+/CD8+ T cells, CD4+ Perforin+ T cells, CD8+ Perforin+Fig. 1. The percentages of CD4+ IL-17+ T cells, CD25+ Foxp3+ T cells were investigated by
pictures for Th17 (CD4+ IL-17+) cells gated on CD4+ T cells by ﬂow cytometry in each gro
percentages of Th17 cells and CD4+ T cells, respectively. B. Representative pictures for the an
cells was gated on CD4+ T cells. Numbers in upper right quadrants and lower left quadrants in
C. Statistic analysis showed the variation of CD4+ IL-17+ T cells at all time points in each group
time points in each group (pb0.01). The data fromeightmice per group are showed asmean±S
by two-way ANOVA, individually. ** pb0.01 vs control group,## pb0.01 day 10 vs days 7 and 1T cells, CD4+CD25+Foxp3+ cells and CVB3 copies in spleen upon
neutralization of IL-17.
The percentage of CD4+ CD25+Foxp3+ T cells increased greatly in
the AVMC, isotype control and anti-IL-17 groups compared to the
control group. Additionally, the percentages of CD4+ CD25+Foxp3+
T cells were lower in the anti-IL-17 group than those in isotype con-
trol group (all pb0.01) (Fig. 3A). Accordingly, the percentages of
CD4+ Perforin+ and CD8+ Perforin+ T cells increased greatly in the
AVMC, isotype control and anti-IL-17 groups compared to the control
group. However, these percentages were higher in the anti-IL-17
group than those in the isotype control group (all pb0.01) (Fig. 3B).
A marked reduction was observed in the CD4+ and CD8+ T cell per-
centages and the ratios of CD4+/CD8+ T cells in the AVMC, isotype
control and anti-IL-17 groups compared to the control group. Howev-
er, the percentages of CD4+ and CD8+ T cells were higher in the anti-
IL-17 group than those in the isotype control group (pb0.05), Howev-
er, no difference was observed in terms of the ratios of CD4+/CD8+
T cells between the anti-IL-17 and isotype control groups (Figs. 3C
and D). Interestingly, the pathological score signiﬁcantly increased
in the AVMC, isotype control and anti-IL-17 groups compared to
the control group, whereas the pathological score decreased in the
anti-IL-17 group than that in the isotype control group (pb0.05)
(Fig. 3E). Moreover, no marked difference was detected in the propor-
tion of CD4+, CD8+, CD4+/CD8+ T cells, CD4+Foxp3+, CD4+Perforin+
and CD8+ Perforin+ T cells between the AVMC and isotype groups
(Fig. 3). In addition, the levels of cardiac CVB3 RNA were obviously
higher in the AVMC, isotype control and anti-IL-17 groups than in the
control group (all pb0.01). However, these levels were markedly
lower in the anti-IL-17 group than those in the isotype control group
(pb0.01), and no marked difference was observed between the AVMC
and isotype control group (Fig. 3F).ﬂow cytometry in control and AVMC groups on days 0, 7, 10 and 14. A Representative
up. Numbers in upper right quadrants and lower right quadrants indicate the separate
alysis of CD25+ Foxp3+ Treg cells by ﬂow cytometry. The percentage of Foxp3+ CD25+
dicate the separate percentages of CD25+ Foxp3+ Treg cells and CD4+ T cells, respectively.
(all pb0.01). D. Statistic analysis showed the variation of CD4+ CD25+ Foxp3+ T cells at all
EM, the difference between control andAVMCgroup at different timepointswas analyzed
4 in the AVMC group (n=6).
Fig. 2. ThemRNA expression of related cytokines and CVB3 RNA in the myocardial tissues on day 7 after viral inoculation. The hearts tissues in the control and AVMC group mice (n=8)
were partly removed ondays after CVB3 infection. A, ThemRNA levels of IL-17A (A), TGF-β (B) inmyocardial tissuesweremeasured by real time PCR. C. The correlation analysis of cardiac
IL-17 mRNA and cardiac CVB3 RNA on day 7 post-infection (R=0.897, pb0.01). D. The correlation analysis of cardiac TGF-β and cardiac CVB3 RNA on day 7 (R=−0.913, pb0.01). Each
point represents an individual mouse. GAPDH gene primer sets were used as an internal control. ** pb0.01 vs control group.
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upon neutralization of IL-17
The protein levels of cardiac IL-17A, TGF-β and VP1 were higher in
the AVMC, isotype control and anti-IL-17 groups than in the controlFig. 3. Relationships among pathological score, CVB3 copies and the proportion of CD4
CD4+CD25+Foxp3+ cells in spleen upon neutralization of IL-17. A. Statistic analysis show
each group. B. Statistic analysis showed the percentages of CD4+ Perforin+ and CD8+ Pe
CD4+ and CD8+ T cells were analyzed by ﬂow cytometry in each group. D. Statistic ana
group are showed as mean±SEM and analyzed by one-way analysis of variance, individu
HE staining in the midventricular regions. The differences in the pathological scores were e
by real time PCR on day 7 after CVB3 infection. ** pb0.01 vs control group, * pb0.05 vs congroup (all pb0.01). However, the levels of these proteinsweremarked-
ly lower in the anti-IL-17 group compared to the isotype control group
(pb0.05, pb0.05 and pb0.01, respectively) (Figs. 4A and B). In addition,
the level of the IFN-γ protein was higher in the AVMC, isotype control
and anti-IL-17 groups than in the control group (pb0.05, pb0.05 and+, CD8+, CD4+/CD8+ T cells, CD4+Perforin+ T cells, CD8+ Perforin+ T cells and
ed the percentage of CD25+Foxp3+ cells gated on CD4+ T cells by ﬂow cytometry in
rforin+ T cells in each group. C. The percentages of CD4+ and CD8+ T cells gated on
lysis of the ratio of CD4+/CD8+ T cells in each group. The data from eight mice per
ally. E. The pathological scores of virus myocarditis are shown for different groups by
valuated using the Mann–Whitney U-test. F. The mRNA levels of CVB3 were measured
trol group, ## pb0.01 or # pb0.05 vs isotype control group (n=6).
Fig. 4. The proteins expression of cardiac protein levels of IL-17A, TGF-β, IFN-γ and VP1 examined byWestern blot on day 7 inmyocarditis upon neutralization of IL-17. A Representative
images for protein expression of cardiac IL-17A, TGF-β, IFN-γ and VP1 in different group. In the pictures of Western blot, the treatment group from left to right is control, AVMC, Isotype
control and Anti-IL-17. B. Statistical analysis for the levels of cardiac IL-17A, TGF-β, IFN-γ and VP1 protein. Sixmice per groupwere analyzed on days. ** pb0.01 vs control group, * pb0.05
vs control group, ## pb0.01 vs isotype control group, # pb0.05 vs isotype control group (n=6).
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higher in the anti-IL-17 groups than in the isotype control group
(pb0.05). No signiﬁcant difference was detected between the AVMC
and isotype control groups (Figs. 4A and B).
Expression of Th17 and Treg-related cytokines upon neutralization of IL-17A
The serum levels of Th17 and Treg-related cytokines, such as
IFN-γ, IL-10, IL-2, IL-6, IL-21 and IL-17A were markedly increased in
the AVMC and isotype control groups than in the control group,
while they were fully decreased (except for IFN-γ) in the anti-IL-17
group compared to the isotype control group. Other cytokines could
not be detected or there exists no remarkable differences between
the isotype control and anti-IL-17 groups (Fig. 5).
Discussion
Th17 cells show pro-inﬂammatory functions and play a critical
role in various autoimmune disorders in mice and humans. In con-
trast, Treg cells are important in the maintenance of immune homeo-
stasis in many infectious diseases (Korn et al., 2009; Shi et al., 2010).
Th17 and Treg cells control injury and inﬂammation in the EAM and
may be important in virus-induced myocarditis. In this study, we
mainly clariﬁed whether the Th17/Treg functional imbalance exists
during acute CVB3-induced myocarditis. The results showed that
acute myocarditis exhibited an apparent increase in Th17 cells andTh17-related cytokines (IL-17A, IL-21). These results indicate that
Th17 cells play a critical role in the formation and development of
acute viral myocarditis. Moreover, marked increases were observed
in Treg cells and Treg-related cytokines (TGF-β, IL-10 and IL-6) in
AVMC mice. CVB3-infected myocarditis induced an early immuno-
suppressive response that correlated with a marked increase in the
frequency of Treg cells and the related cytokines TGF-β and IL-10. It
indicates that Treg cells may contribute to viral persistence by prema-
turely limiting the antiviral immune response. The maintenance of
long-term Treg cell activation could contribute to the progressive
loss of CD4+ and CD8+ T cell immune function (anergy) and promote
the development of myocarditis. Intriguingly, our studies further
showed that the replication of CVB3 was associated with the levels
of cardiac IL-17 and TGF-β mRNA. Meanwhile, the results indicated
that the Treg cells and related cytokine TGF-β somewhat decreased
upon treatment with the anti-mouse IL-17Ab to block IL-17 on day 7
in AVMC mice. Conversely, CD4+ Perforin+ and CD8+ Perforin+
T cells were markedly elevated, followed by a marked reduction in
CVB3 replication and a direct decrease in the cardiac inﬂammatory cy-
tokines IL-17A, IL-10, IL-2 and IL-21. These data suggest that a Th17/
Treg function exists and is intimately associated with viral replication
in myocarditis. The results further suggest that Th17 cells would con-
tribute to viral replication possibly by Treg cell-mediated T cell and per-
forin response in Coxsackievirus B3-induced acute myocarditis.
Many viruses, including Coxsackieviruses, have been implicated as
main causes of myocarditis, which is deﬁned as inﬂammation of the
Fig.5. The production of related cytokines of IL-6, IL-17A, IL-21, IL-10, IFN-γ, IL-2 in the serum of different group mice by Flowcytomix bead assay. Results are mean values±SD of
six independent mice. One-way ANOVA was used to analyze the data. ** pb0.01 vs Control group, * pb0.05 vs control group, ## pb0.01 vs isotype control group, # pb0.05 vs
isotype control group (n=6).
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by maintaining an immune response through both innate and
adapted immunity. Moreover, early investigations have suggested
that local heart tissue damage associated with viral infection was
mediated by primary T cells (Afanasyeva et al., 2001). CD4+ T cells
play a critical role in the induction of autoimmune myocarditis
(Blauwet and Cooper, 2010). Furthermore, deﬁciencies in CD4+
T cells are associatedwith virus reactivation, generalized susceptibil-
ity to opportunistic infections and poor vaccine efﬁcacy (Whitmire,
2011). The marked reduction of inﬂammation in infected mice after
depletion of CD4+ T cells highlights a potential contribution of
CD4+ T cells in the progression of myocarditis in CVB3-infected
mice (Huber et al., 2002; Neu et al., 1993). In this study, we clariﬁed
that the percentage of CD4+ T cells markedly decreased in AVMC
mice. Previous studies have indicated that Th1 cells play a pivotal
role in the adaptive immune response, mainly because these cells
can secret cytokines and chemokines for the effective clearance of
viral infections and can down-regulate the immune response in the
progression of myocarditis. In addition, IFN-γ, the prototypic cyto-
kine associated with Th1 immune responses, was formerly consid-
ered to be essential for the development of EAM (Fairweather et al.,
2005). However, many experiences have shown that IFN-γ has a
protective effect in the pathology of autoimmune disease, and
this effect had been ascribed to the deregulation of IL-17, resulting
from the regulation of the Th17-associated transcription factor RORγt
(Ivanov et al., 2007). Our data showed that expression of splenic Th17
cells and Th17-related cytokines (IL-17A) increased in AVMC mice.
Furthermore, cardiac IL-17A mRNA positively correlated with cardiac
viral replication. These data suggested that Th17 cells might contribute
to viral replication in CVB3-induced AVMC. Most importantly, the
results demonstrated that the neutralization of IL-17 promoted
higher production of IFN-γ, which promoted Th1 cell function
and efﬁciently controlled virus load, along with the reduction of
IL-17A and IL-21, indicating that Th17 cells might contribute to
virus load by the inhibitory effect of IL-17 on Th1 cell differentia-
tion. Estes et al. (2006) reported that simian immunodeﬁciency
virus (SIV) infection of Macaques induced an early immunosup-
pressive response that correlated with a marked increase in frequency
of CD4+CD25+Foxp3+ Treg cells and TGF-β and IL-10 positive T cells,
indicating that Treg cells and/or anti-inﬂammatory cytokines may pos-
sibly contribute to viral persistence by prematurely limiting the anti-
viral immune response. Also, a role for CD4+CD25+Foxp3+ Treg cells
on the CD4+ and CD8+ T cells anergy to HIV peptide stimulation in
vitro (Aandahl et al., 2004; Eggena et al., 2005; Wherry et al., 2006).
In short, HIV-speciﬁc T cells response during acute stage infection may
involve epitope speciﬁc clonal anergy rather than clonal deletion, and
this anergy may be mediated by active Treg cells. However, severalchronic viral infections, including HCV, HIV, HTLV-1, FIV, Friend virus
and the murine form of AIDS, have additionally been linked to unregu-
lated Treg cell activation and suppressor function (Vahlenkamp et al.,
2005). In the course of investigating the relationship between Th17
and Treg cells in the AVMC model, we found that the expression of
splenic Treg cells and Treg-related cytokines (TGF-β, IL-6, IL-10) levels
remarkably increased in acute virus myocarditis. In addition, CD4+
T cells, CD8+ T cells and the ratio of CD4+/CD8+ T cells were fully
down-regulated in AVMC mice. From the studies described above,
viral infections are clearly characterized by an early and sustained acti-
vation of immunosuppressive Foxp3+ Treg cells that are capable of
inhibiting anti-viral CD4+ and CD8+ T cell immune responses, which
allows for the establishment of long-term infection. Furthermore, cardi-
ac TGF-βmRNAwas negatively correlatedwith cardiac viral replication.
The present study showed that CVB3-infected myocarditis induced an
early immunosuppressive response that correlated with the frequency
and levels of Treg-related cytokines, and indicating that Treg cells may
contribute to viral persistence by prematurely limiting the antiviral im-
mune response. These data suggest that Treg cells, which attained a dis-
tinct immunosuppressive property in various aspects of immune
response and maintained self-tolerance, might also contribute to viral
replication in CVB3-induced acute myocarditis.
Th17 and Treg cells and the developmental programs of T cells are
reciprocally interconnected. This discovery was initially based on the
observation that upon TCR stimulation, a naïve T cell can be driven to
express Foxp3 and become a Treg cell in the presence of TGF-β. How-
ever, in the presence of TGF-β plus IL-6 or IL-21, the Treg develop-
mental pathway is abrogated, and instead of the T cells developing
into Th17 cells (Veldhoen et al., 2006). Certainly, TGF-β is a regulato-
ry cytokine with a pleiotropic function in T cell development, homeo-
stasis and tolerance (Korn et al., 2009; Mesa et al., 2010). Moreover,
TGF-β has certainly been recognized as a hub between Th17 and
Treg cells. In addition, IL-2 is required for the generation and mainte-
nance of Treg in many infectious diseases (Laurence et al., 2007;
Papiernik et al., 1998). Increasing evidence suggests that Th17 cells
and Treg cells have evolved greater developmental plasticity than
Th1 and Th2 subsets (Lee et al., 2009). Previous studies provided
that Th17 clones can differentiate into IFN-γ-producing and Foxp3+
populations after multiple in vitro TCR stimulations and expansions,
and that these expanded Th17 clones convert into Treg cells posses-
sing potent suppressive activity (Ye et al., 2011). The functional
roles, the regulatory mechanisms of Th17 cells, Treg cells and Th1
cells in vivo under different pathological conditions will be needed
to further investigate. Certainly, we have observed that Th17 cells
and Treg cells increased drastically and had played a vital role in the
pathological condition of CVB3-induced myocarditis. Whether alter-
ing the Th17-cell-polarizing conditions upon neutralization of IL-17
83Y. Xie et al. / Virology 421 (2011) 78–84signiﬁcantly decreased differentiation of Treg cell and affect CVB3 rep-
lication remained a question to be addressed. In this study, an anti-
IL-17 antibody was used to block IL-17 on day 7 in AVMC mouse
model. We found that Treg cells possessing potent suppressive activity
somewhat decreased upon neutralization of IL-17, but importantly, a
direct decreased in the cardiac inﬂammatory cytokines which local en-
vironment of differentiation of Th17 and Treg such as TGF-β, IL-6, and
IL-2. We speculated that neutralization of IL-17 could alter the patho-
logical conditions of acute myocarditis and decrease the percentage
of Th17-derived Treg cells. Thus, it could alleviate the immunosup-
pressive response of activated Treg, in turn leading to clonal expan-
sion of cytotoxic T cells and the development of an effective immune
response in the early acute stage of the CVB3-induced myocarditis, in
which cytotoxic T cells are able to induce apoptosis of the virus-infected
cells through a perforin-mediated apoptosis pathway. In this apoptotic
mechanism, perforin polymerizes and forms a transmembrane pore
that allows the delivery of granzymes into the cytosol, where they
initiate various apoptotic death pathways. Unlike relatively redundant
individual granzymes, functional perforin is absolutely essential for
cytotoxic lymphocyte function and immune regulation in the host
(Voskoboinik et al., 2010). In conclusion, these data showed that
the Th17 and Treg cells are involved in CVB3-induced acute autoim-
mune myocarditis, and this study partially elucidated that anti-IL-17
antibody and/or Treg cells may be considered as a potential immune
therapy in viral myocarditis. Clinical trials showed that immunosup-
pressive agents had no signiﬁcant beneﬁt for outcome of human
myocarditis. New therapeutic strategies in viral myocarditis might
be taken into account the interaction of Th17 and Treg cells. Taken to-
gether, pan-immune suppression, perhaps, is not the better treatment
of acute CVB3-induced myocarditis. Consequently, more effective and
targeted approaches to mediate the immune function of Th17 and
Treg cells are needed in the course of viral myocarditis.Materials and methods
Virus
The CVB3 (Nancy strain)was prepared by passage through HeLa cell
cultures and then titered by a plaque assay and stored at−80 °C. The
virus titer was determined by the median tissue culture infective dose
(TCID50=107, Nancy strain) in 100 μl of Eagle's minimal essential
medium (EMEM, GIBCO) (Chen et al., 2011).Mice
BALB/c mice (4–6 weeks old) were purchased from the Joint Ven-
tures Sipper BK Experimental Animal Company. All animal experi-
ments were performed in accordance with the National Institute of
Health guide for the Care and Use of Laboratory Animals, with the ap-
proval of the Animal Care Committee of the Zhongshan Hospital afﬁl-
iated with Fudan University (Shanghai, China). BALB/c mice were
randomly divided into four groups: (1) Normal control group
(n=60) mice were injected intraperitoneally (i.p.) with 100 μl of
EMEM, (2) AVMC group (n=60) mice were injected i.p. with 100 μl
of CVB3 diluted in EMEM on day 0 to induce acute viral myocarditis
after days 7, 10 and 14, (3) Isotype control group (n=25) mice
were treated with CVB3 i.p. on day 0 and isotype control IgG1 Ab
(100 μg per mouse; eBioscience) i.p. on days 3 and 5, and (4) IL-
17mAb group (n=25) mice were treated with CVB3 i.p. on day
0 and anti-mouse IL-17 mAb (100 μg per mouse; R&D Systems, Inc)
i.p. on days 3 and 5 (Baldeviano et al., 2010). The mice in isotype con-
trol group and anti-mouse IL-17mAb group were sacriﬁced on day 7
post-infection (Chen et al., 2009). All mice were kept in speciﬁc
pathogen-free conditions.Histopathology
Parafﬁn-embedded hearts were cut into 5 μm-thick tissue sections
and stained with hematoxylin & eosin (H&E) and Masson trichrome
staining to assess myocardial injury and inﬂammation. Pathological
grading of inﬂammation of the myocardium was evaluated by giving
the samples a myocarditis score from 0 to 4 according to a previous
study (Valaperti et al., 2008) with slight modiﬁcations (score: 0, no
inﬂammatory inﬁltrates; 1, small foci of inﬂammatory cells between
myocytes; 2, 5% to 10% of a cross-section involved; 3, 10% to 25% of
a cross-section involved; 4, N25% of a cross-section involved). The slides
were graded independently in a masked fashion by two observers. For
immunohistochemical analysis, parafﬁn-embedded sections were ﬁrst
deparafﬁnized and hydrated, then microwave antigen retrieval was
performed, endogenous peroxidase activity was blocked by incubation
of the slides in 0.3% H2O2, and non-speciﬁc binding sites were blocked
with 4% BSA (Sigma).
Flow cytometric analysis
Splenocytes were isolated and suspended in RPMI 1640 containing
10% fetal bovine serum, and red blood cells were lysed by 3 min incuba-
tion in ACK lysis buffer (TIANGEN, China). Cells were collected and
resuspended at a density of 1.0×106/ml. Then, the cells were stimulat-
ed for 4 h with 50 ng/ml phorbol 12-myristate 13 acetate (PMA) and
1 μg/ml ionomycin (all from Sigma-Aldrich, St. Louis, MO), and cytokine
secretion was blocked using 10 μg/ml brefeldin A (Sigma-Aldrich) at
37 °C, 5% CO2 in a 24-well culture plate (Corning Costar, Corning, NY)
in RPMI 1640 medium supplemented with 100 U/ml penicillin,
100 μg/ml streptomycin and 10% FBS. Surface markers were stained
with FITC-labeled anti-mouse CD4 or CD8 (eBiosciences, San Diego,
CA), or PE-conjugated anti mouse CD25 (eBiosciences). After washing,
ﬁxing and permeabilizing according to the manufacturer's instruc-
tions (eBiosciences), the cells were stained intracellularly with APC-
conjugated anti-mouse Foxp3 (eBiosciences), PE-labeled anti-mouse
IL-17A (TC11-18H10, BD Biosciences, San Jose, CA) or anti-mouse
perforin (eBiosciences). After incubation at 4 °C for 30 min, the samples
were ﬁnally washed in staining buffer andmeasured by ﬂow cytometry
on a FACSCalibur machine. The data were analyzed with CellQuest soft-
ware (BD Biosciences).
Real time PCR
Total RNAwas isolated from each preparation using Trizol® reagent
(Invitrogen, USA) according to the manufacturer's instructions and
converted into cDNA using M-MuLV reverse transcriptase (Fermentas
International Inc, Canada). cDNA was ampliﬁed with a SYBR green
master mix (TaKaRa, China) using an ABI7500 thermocycler (Applied
Biosystems). The 2−ΔCT method (Schmittgen and Livak, 2008) was
used to normalize transcription to GAPDH mRNA and calculate the
fold induction relative to control. The primer pairs that were used are
shown in Table 1.
Western blot
The total proteins of the heart tissues were lysed in RIPA lysis buffer,
which contained a protease and phosphatase inhibitor cocktail (AG
Scientiﬁc). Protein concentration was quantiﬁed using a bicinchoninic
(BCA) protein assay kit (Pierce). Samples containing 50 μg of proteins
were separated on an 8% to 12% SDS-PAGE gel and transferred to poly-
vinylidene diﬂuoride membranes. Membranes were blocked for 2 h at
room temperature with 2–5% BSA, reacted with anti-IFN-γ antibody
(1:500, Santa Cruz Biotechnology, CA USA), anti-IL-17A antibody
(1:1000, Cell Signaling Technology), anti-TGF-β antibody (1:500,
Santa Cruz Biotechnology), anti-VP1 antibody (1:300, Leica Microsys-
tems) or anti-GAPDH antibody (1:1000, Kangchen Biotech, China) at
Table 1










⁎ IL-17A = interleukin-17A; TGF-β = transforming growth factor-β; CVB3 = Cox-
sackieviruses B3.
84 Y. Xie et al. / Virology 421 (2011) 78–844 °C overnight, and then incubated with a secondary HRP-conjugated
antibody (1:2000, Kangchen Biotech) for 1 h at room temperature.
After incubation with the secondary antibody, the blots were detected
with ECL (Thermo Scientiﬁc). The bands obtained were analyzed
using “Quantity One” software (Bio-Rad). Ratios were compared using
the expression of the bands in a ratio with GAPDH expression for the
same sample.
Multiple cytokine detection
Serum was collected after centrifugation and stored at −80 °C. A
bead-based multiplexed assay (FlowCytomix mouse Th1/Th2/Th17/
Th22 13plex Sample Kit; Bender MedSystems) that quantiﬁes multi-
ple cytokines was used for analysis of cytokine expression patterns
(Figueiredo et al., 2009). Cytokine levels were measured according to
the manufacturer's instructions. All samples were measured in triplicate.
Statistics
Comparisons of different treatment groups were performed by one-
wayANOVA.Data fromcontrol andAVMCgroup at different time points
were subjected to two-way ANOVA analysis. The differences in the
pathological scores were evaluated using a Mann–Whitney U-test. The
statistical package employed was SPSS 16.0 for Windows. Values are
expressed asmean±SEM,with values of pb0.05 considered signiﬁcant.
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